GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing new treatments for neurodegenerative and autoimmune diseases, announces that the Geneva Court of First Instance ...
Switzerland has long been synonymous with innovation, stability, and economic prosperity. From its world-class infrastructure to a robust financial services sector, it consistently ranks as one of the ...